Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
131I-tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: radiation dose to the testes.
Nuclear Medicine Communications (2012)
  • Naoya Hattori, University of Washington
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
  • Andrew T. Shields, University of Washington
  • Darrell R. Fisher, Pacific Northwest National Laboratory
  • Ted Gooley, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • Joseph G. Rajendran, University of Washington
Link
Disciplines
Publication Date
January 12, 2012
DOI
10.1097/MNM.0b013e328358d34b
Citation Information
Naoya Hattori, Ajay K. Gopal, Andrew T. Shields, Darrell R. Fisher, et al.. "131I-tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: radiation dose to the testes." Nuclear Medicine Communications Vol. 33 Iss. 12 (2012) p. 1225 - 1231
Available at: http://works.bepress.com/john-pagel/157/